Esther Carrasco

2.0k total citations
33 papers, 1.5k citations indexed

About

Esther Carrasco is a scholar working on Molecular Biology, Ophthalmology and Oncology. According to data from OpenAlex, Esther Carrasco has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Ophthalmology and 8 papers in Oncology. Recurrent topics in Esther Carrasco's work include Retinal Diseases and Treatments (9 papers), Glaucoma and retinal disorders (8 papers) and Retinal Imaging and Analysis (4 papers). Esther Carrasco is often cited by papers focused on Retinal Diseases and Treatments (9 papers), Glaucoma and retinal disorders (8 papers) and Retinal Imaging and Analysis (4 papers). Esther Carrasco collaborates with scholars based in Spain, United States and Colombia. Esther Carrasco's co-authors include Cristina Hernández, Rafael Simó, Marta García‐Ramírez, Jaume Farrés, Pablo Álvarez, Antonia Aránega, José Garcia-Arumı́, Fernando Rodríguez‐Serrano, Alex Fonollosa and Rosa Segura and has published in prestigious journals such as PLoS ONE, Diabetes Care and FEBS Letters.

In The Last Decade

Esther Carrasco

33 papers receiving 1.5k citations

Peers

Countries citing papers authored by Esther Carrasco

Since Specialization

Citations

This map shows the geographic impact of Esther Carrasco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Carrasco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Carrasco more than expected).

Fields of papers citing papers by Esther Carrasco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Carrasco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Carrasco. The network helps show where Esther Carrasco may publish in the future.

Co-authorship network of co-authors of Esther Carrasco

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Carrasco. A scholar is included among the top collaborators of Esther Carrasco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Carrasco. Esther Carrasco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of novel 2,3,5-trisubstituted pyridine analogs as potent inhibitors of IL-1β via modulation of the p38 MAPK signaling pathway 2021 ·European Journal of Medicinal Chemistry ·Esther Carrasco, (unknown), (unknown), Miguel A. Vega, Ángel Messeguer, Juan J. Pérez	7
2	Mesenchymal stem cell's secretome promotes selective enrichment of cancer stem-like cells with specific cytogenetic profile 2018 ·Cancer Letters ·Gema Jiménez, Michael Hackenberg, Purificación Catalina, Houría Boulaiz, Carmen Griñán‐Lisón, María Ángel García, Macarena Perán, Elena López‐Ruiz, Alberto Ramírez, Cynthia Morata‐Tarifa, Esther Carrasco, Jaime Aguilera, Juan Antonio Marchal	32
3	Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses 2017 ·Frontiers in Immunology ·Esther Carrasco, (unknown), Núria Climent, (unknown), (unknown), Mario Martínez‐Florensa, Adélaïda Sarukhan, Esther Carreras, Francisco Lozano	19
4	Pattern Recognition by CD6: A Scavenger-Like Lymphocyte Receptor 2016 ·Current Drug Targets ·Adélaïda Sarukhan, Mario Martínez‐Florensa, (unknown), Esther Carrasco, Esther Carreras, Francisco Lozano	13
5	Meroxest improves the prognosis of immunocompetent C57BL/6 mice with allografts of E0771 mouse breast tumor cells 2016 ·Archives of Medical Science ·Esther Carrasco, José Manuel Garrido, Pablo Álvarez, Enrique Álvarez‐Manzaneda, Rachid Chahboun, (unknown), Consolación Melguizo, Antonia Aránega, Fernando Rodríguez‐Serrano	12
6	Functionalized immunostimulating complexes with protein A via lipid vinyl sulfones to deliver cancer drugs to trastuzumab-resistant HER2-overexpressing breast cancer cells 2016 ·International Journal of Nanomedicine ·Antonio Osuna, Fernando Rodríguez‐Serrano, Nuria Mut‐Salud, (unknown), (unknown), Esther Carrasco, José Manuel Garrido, Javier López-Jaramillo, Francisco Santoyo‐González	7
7	Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis 2016 ·Antimicrobial Agents and Chemotherapy ·Mario Martínez‐Florensa, Marta Consuegra‐Fernández, Fernando Aranda, (unknown), Marianna Di Scala, Esther Carrasco, Jerónimo Pachón, Jordi Vilà, Gloria González‐Aseguinolaza, Francisco Lozano	13
8	Antioxidant Intake and Antitumor Therapy: Toward Nutritional Recommendations for Optimal Results 2015 ·Oxidative Medicine and Cellular Longevity ·Nuria Mut‐Salud, Pablo Álvarez, José Manuel Garrido, Esther Carrasco, Antonia Aránega, Fernando Rodríguez‐Serrano	128
9	A Role for Scavenger-like Lymphocyte Receptor CD6 in HIV-1 Viral Infection 2014 ·AIDS Research and Human Retroviruses ·Esther Carrasco, (unknown), (unknown), Sonsoles Sánchez‐Palomino, Esther Carreras, José María Gatell, Teresa Gallart, Felipe García, Núria Climent, (unknown)	7
10	Novel merosesquiterpene exerts a potent antitumor activity against breast cancer cells in vitro and in vivo 2014 ·European Journal of Medicinal Chemistry ·Esther Carrasco, Pablo Álvarez, Consolación Melguizo, José Prados, Enrique Álvarez‐Manzaneda, Rachid Chahboun, (unknown), (unknown), Antonia Aránega, Fernando Rodríguez‐Serrano	20
11	Application of Nanotechnology in the Treatment and Diagnosis of Gastrointestinal Cancers: Review of Recent Patents 2013 ·Recent Patents on Anti-Cancer Drug Discovery ·José Prados, Consolación Melguizo, Gloria Perazzoli, Laura Cabeza, Esther Carrasco, (unknown), Cristina Jiménez‐Luna, María C. Leiva, Raúl Ortíz, (unknown), Antonia Aránega	10
12	Enantiospecific Synthesis of Heterocycles Linked to Purines: Different Apoptosis Modulation of Enantiomers in Breast Cancer Cells 2013 ·Current Medicinal Chemistry ·María Eugenia García-Rubiño, Ana Conejo‐García, María Núñez, Esther Carrasco, María Ángel García, Duane Choquesillo‐Lazarte, Juan Manuel García‐Ruiz, M.Á. Gallo, Juan Antonio Marchal, Joaquín M. Campos Rosa	8
13	Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence 2013 ·Drug Design Development and Therapy ·María Ángel García, Juan Antonio Marchal, Esther Carrasco, Alberto Ramírez, Gema Jiménez, Carmen Olmedo, Macarena Perán, Ahmad Agil, Ana Conejo‐García, Olga Cruz‐López, Joaquín M. Campos Rosa	19
14	The Chemotherapeutic Drug 5-Fluorouracil Promotes PKR-Mediated Apoptosis in a p53- Independent Manner in Colon and Breast Cancer Cells 2011 ·PLoS ONE ·María Ángel García, Esther Carrasco, Jaime Aguilera, Pablo Álvarez, Carmen Rivas, Joaquín M. Campos Rosa, José Prados, Miguel Ángel Calleja, Mariano Estéban, Juan Antonio Marchal, Antonia Aránega	43
15	A Sensitive Method for Detecting EGFR Mutations in Non-small Cell Lung Cancer Samples with Few Tumor Cells 2008 ·Journal of Thoracic Oncology ·Miguel Ángel Molina‐Vila, Jordi Bertran-Alamillo, Noemı́ Reguart, Miquel Tarón, Eva Castellà, Mariona Llatjós, Carlota Costa, Clara Mayo, (unknown), Cristina Queralt, Mónica Botia, (unknown), Esther Carrasco, (unknown), José Luís Mate, Teresa Morán, Rafael Rosell	83
16	BRCA1: A New Genomic Marker for Non–Small-Cell Lung Cancer 2008 ·Clinical Lung Cancer ·Noemı́ Reguart, Andrés F. Cardona, Esther Carrasco, (unknown), Miquel Tarón, Rafael Rosell	37
17	Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy 2007 ·Diabetologia ·Marta García‐Ramírez, Françesc Canals, Cristina Hernández, Núria Colomé, Cristina Suárez Ferrer, Esther Carrasco, José Garcia-Arumı́, Rafael Simó	134
18	Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy 2006 ·Current Diabetes Reviews ·Rafael Simó, Esther Carrasco, Marta García‐Ramírez, Cristina Hernández	311
19	Interleukin‐8, monocyte chemoattractant protein‐1 and IL‐10 in the vitreous fluid of patients with proliferative diabetic retinopathy 2005 ·Diabetic Medicine ·Cristina Hernández, Rosa Segura, Alex Fonollosa, Esther Carrasco, (unknown), Rafael Simó	156
20	Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: A case-control study 2005 ·Diabetes Research and Clinical Practice ·Rafael Simó, María Vidal, José Garcia-Arumı́, Esther Carrasco, Marta García‐Ramírez, Rosa Segura, Cristina Hernández	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact